Controlled Substances Market Report

Global Controlled Substances Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：197
  • REPORT CODE：GMM834568
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Controlled Substances market report explains the definition, types, applications, major countries, and major players of the Controlled Substances market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sun Pharmaceutical

    • Daiichi Sankyo

    • Mylan

    • Teva Pharmaceuticals

    • Purdue Pharma

    • GlaxoSmithKline

    • Medical Marijuana Inc

    • Akorn Inc

    • Tilray

    • Pfizer

    • Consort Medical

    • Siegfried AG

    • Johnson & Johnson

    • Takeda Pharmaceutical

    By Type:

    • Opioids

    • Stimulants

    • Depressants

    • Marijuana

    • Others

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Controlled Substances Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Controlled Substances Outlook to 2028- Original Forecasts

    • 2.2 Controlled Substances Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Controlled Substances Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Controlled Substances Market- Recent Developments

    • 6.1 Controlled Substances Market News and Developments

    • 6.2 Controlled Substances Market Deals Landscape

    7 Controlled Substances Raw Materials and Cost Structure Analysis

    • 7.1 Controlled Substances Key Raw Materials

    • 7.2 Controlled Substances Price Trend of Key Raw Materials

    • 7.3 Controlled Substances Key Suppliers of Raw Materials

    • 7.4 Controlled Substances Market Concentration Rate of Raw Materials

    • 7.5 Controlled Substances Cost Structure Analysis

      • 7.5.1 Controlled Substances Raw Materials Analysis

      • 7.5.2 Controlled Substances Labor Cost Analysis

      • 7.5.3 Controlled Substances Manufacturing Expenses Analysis

    8 Global Controlled Substances Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Controlled Substances Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Controlled Substances Export by Region (Top 10 Countries) (2017-2028)

    9 Global Controlled Substances Market Outlook by Types and Applications to 2022

    • 9.1 Global Controlled Substances Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Opioids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Stimulants Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Depressants Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Marijuana Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Controlled Substances Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Controlled Substances Market Analysis and Outlook till 2022

    • 10.1 Global Controlled Substances Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Controlled Substances Consumption (2017-2022)

      • 10.2.2 Canada Controlled Substances Consumption (2017-2022)

      • 10.2.3 Mexico Controlled Substances Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Controlled Substances Consumption (2017-2022)

      • 10.3.2 UK Controlled Substances Consumption (2017-2022)

      • 10.3.3 Spain Controlled Substances Consumption (2017-2022)

      • 10.3.4 Belgium Controlled Substances Consumption (2017-2022)

      • 10.3.5 France Controlled Substances Consumption (2017-2022)

      • 10.3.6 Italy Controlled Substances Consumption (2017-2022)

      • 10.3.7 Denmark Controlled Substances Consumption (2017-2022)

      • 10.3.8 Finland Controlled Substances Consumption (2017-2022)

      • 10.3.9 Norway Controlled Substances Consumption (2017-2022)

      • 10.3.10 Sweden Controlled Substances Consumption (2017-2022)

      • 10.3.11 Poland Controlled Substances Consumption (2017-2022)

      • 10.3.12 Russia Controlled Substances Consumption (2017-2022)

      • 10.3.13 Turkey Controlled Substances Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Controlled Substances Consumption (2017-2022)

      • 10.4.2 Japan Controlled Substances Consumption (2017-2022)

      • 10.4.3 India Controlled Substances Consumption (2017-2022)

      • 10.4.4 South Korea Controlled Substances Consumption (2017-2022)

      • 10.4.5 Pakistan Controlled Substances Consumption (2017-2022)

      • 10.4.6 Bangladesh Controlled Substances Consumption (2017-2022)

      • 10.4.7 Indonesia Controlled Substances Consumption (2017-2022)

      • 10.4.8 Thailand Controlled Substances Consumption (2017-2022)

      • 10.4.9 Singapore Controlled Substances Consumption (2017-2022)

      • 10.4.10 Malaysia Controlled Substances Consumption (2017-2022)

      • 10.4.11 Philippines Controlled Substances Consumption (2017-2022)

      • 10.4.12 Vietnam Controlled Substances Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Controlled Substances Consumption (2017-2022)

      • 10.5.2 Colombia Controlled Substances Consumption (2017-2022)

      • 10.5.3 Chile Controlled Substances Consumption (2017-2022)

      • 10.5.4 Argentina Controlled Substances Consumption (2017-2022)

      • 10.5.5 Venezuela Controlled Substances Consumption (2017-2022)

      • 10.5.6 Peru Controlled Substances Consumption (2017-2022)

      • 10.5.7 Puerto Rico Controlled Substances Consumption (2017-2022)

      • 10.5.8 Ecuador Controlled Substances Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Controlled Substances Consumption (2017-2022)

      • 10.6.2 Kuwait Controlled Substances Consumption (2017-2022)

      • 10.6.3 Oman Controlled Substances Consumption (2017-2022)

      • 10.6.4 Qatar Controlled Substances Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Controlled Substances Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Controlled Substances Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Controlled Substances Consumption (2017-2022)

      • 10.7.2 South Africa Controlled Substances Consumption (2017-2022)

      • 10.7.3 Egypt Controlled Substances Consumption (2017-2022)

      • 10.7.4 Algeria Controlled Substances Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Controlled Substances Consumption (2017-2022)

      • 10.8.2 New Zealand Controlled Substances Consumption (2017-2022)

    11 Global Controlled Substances Competitive Analysis

    • 11.1 Sun Pharmaceutical

      • 11.1.1 Sun Pharmaceutical Company Details

      • 11.1.2 Sun Pharmaceutical Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sun Pharmaceutical Controlled Substances Main Business and Markets Served

      • 11.1.4 Sun Pharmaceutical Controlled Substances Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Daiichi Sankyo

      • 11.2.1 Daiichi Sankyo Company Details

      • 11.2.2 Daiichi Sankyo Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Daiichi Sankyo Controlled Substances Main Business and Markets Served

      • 11.2.4 Daiichi Sankyo Controlled Substances Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Mylan

      • 11.3.1 Mylan Company Details

      • 11.3.2 Mylan Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Mylan Controlled Substances Main Business and Markets Served

      • 11.3.4 Mylan Controlled Substances Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Teva Pharmaceuticals

      • 11.4.1 Teva Pharmaceuticals Company Details

      • 11.4.2 Teva Pharmaceuticals Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Teva Pharmaceuticals Controlled Substances Main Business and Markets Served

      • 11.4.4 Teva Pharmaceuticals Controlled Substances Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Purdue Pharma

      • 11.5.1 Purdue Pharma Company Details

      • 11.5.2 Purdue Pharma Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Purdue Pharma Controlled Substances Main Business and Markets Served

      • 11.5.4 Purdue Pharma Controlled Substances Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 GlaxoSmithKline

      • 11.6.1 GlaxoSmithKline Company Details

      • 11.6.2 GlaxoSmithKline Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 GlaxoSmithKline Controlled Substances Main Business and Markets Served

      • 11.6.4 GlaxoSmithKline Controlled Substances Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Medical Marijuana Inc

      • 11.7.1 Medical Marijuana Inc Company Details

      • 11.7.2 Medical Marijuana Inc Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Medical Marijuana Inc Controlled Substances Main Business and Markets Served

      • 11.7.4 Medical Marijuana Inc Controlled Substances Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Akorn Inc

      • 11.8.1 Akorn Inc Company Details

      • 11.8.2 Akorn Inc Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Akorn Inc Controlled Substances Main Business and Markets Served

      • 11.8.4 Akorn Inc Controlled Substances Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Tilray

      • 11.9.1 Tilray Company Details

      • 11.9.2 Tilray Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Tilray Controlled Substances Main Business and Markets Served

      • 11.9.4 Tilray Controlled Substances Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Pfizer

      • 11.10.1 Pfizer Company Details

      • 11.10.2 Pfizer Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Pfizer Controlled Substances Main Business and Markets Served

      • 11.10.4 Pfizer Controlled Substances Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Consort Medical

      • 11.11.1 Consort Medical Company Details

      • 11.11.2 Consort Medical Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Consort Medical Controlled Substances Main Business and Markets Served

      • 11.11.4 Consort Medical Controlled Substances Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Siegfried AG

      • 11.12.1 Siegfried AG Company Details

      • 11.12.2 Siegfried AG Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Siegfried AG Controlled Substances Main Business and Markets Served

      • 11.12.4 Siegfried AG Controlled Substances Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Johnson & Johnson

      • 11.13.1 Johnson & Johnson Company Details

      • 11.13.2 Johnson & Johnson Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Johnson & Johnson Controlled Substances Main Business and Markets Served

      • 11.13.4 Johnson & Johnson Controlled Substances Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Takeda Pharmaceutical

      • 11.14.1 Takeda Pharmaceutical Company Details

      • 11.14.2 Takeda Pharmaceutical Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Takeda Pharmaceutical Controlled Substances Main Business and Markets Served

      • 11.14.4 Takeda Pharmaceutical Controlled Substances Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global Controlled Substances Market Outlook by Types and Applications to 2028

    • 12.1 Global Controlled Substances Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Opioids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Depressants Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Marijuana Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Controlled Substances Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Controlled Substances Market Analysis and Outlook to 2028

    • 13.1 Global Controlled Substances Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Controlled Substances Consumption Forecast (2022-2028)

      • 13.2.2 Canada Controlled Substances Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Controlled Substances Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.2 UK Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.3 Spain Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.5 France Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.6 Italy Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.8 Finland Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.9 Norway Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.11 Poland Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.12 Russia Controlled Substances Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Controlled Substances Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.2 Japan Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.3 India Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Controlled Substances Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Controlled Substances Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Controlled Substances Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Controlled Substances Consumption Forecast (2022-2028)

      • 13.5.3 Chile Controlled Substances Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Controlled Substances Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Controlled Substances Consumption Forecast (2022-2028)

      • 13.5.6 Peru Controlled Substances Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Controlled Substances Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Controlled Substances Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Controlled Substances Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Controlled Substances Consumption Forecast (2022-2028)

      • 13.6.3 Oman Controlled Substances Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Controlled Substances Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Controlled Substances Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Controlled Substances Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Controlled Substances Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Controlled Substances Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Controlled Substances Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Controlled Substances Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Controlled Substances Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Controlled Substances Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Controlled Substances

    • Figure of Controlled Substances Picture

    • Table Global Controlled Substances Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Controlled Substances Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Opioids Consumption and Growth Rate (2017-2022)

    • Figure Global Stimulants Consumption and Growth Rate (2017-2022)

    • Figure Global Depressants Consumption and Growth Rate (2017-2022)

    • Figure Global Marijuana Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Controlled Substances Consumption by Country (2017-2022)

    • Table North America Controlled Substances Consumption by Country (2017-2022)

    • Figure United States Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Canada Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Mexico Controlled Substances Consumption and Growth Rate (2017-2022)

    • Table Europe Controlled Substances Consumption by Country (2017-2022)

    • Figure Germany Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure UK Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Spain Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Belgium Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure France Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Italy Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Denmark Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Finland Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Norway Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Sweden Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Poland Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Russia Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Turkey Controlled Substances Consumption and Growth Rate (2017-2022)

    • Table APAC Controlled Substances Consumption by Country (2017-2022)

    • Figure China Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Japan Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure India Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure South Korea Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Thailand Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Singapore Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Philippines Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Controlled Substances Consumption and Growth Rate (2017-2022)

    • Table South America Controlled Substances Consumption by Country (2017-2022)

    • Figure Brazil Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Colombia Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Chile Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Argentina Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Peru Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Controlled Substances Consumption and Growth Rate (2017-2022)

    • Table GCC Controlled Substances Consumption by Country (2017-2022)

    • Figure Bahrain Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Oman Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Qatar Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Controlled Substances Consumption and Growth Rate (2017-2022)

    • Table Africa Controlled Substances Consumption by Country (2017-2022)

    • Figure Nigeria Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure South Africa Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Egypt Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure Algeria Controlled Substances Consumption and Growth Rate (2017-2022)

    • Table Oceania Controlled Substances Consumption by Country (2017-2022)

    • Figure Australia Controlled Substances Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Controlled Substances Consumption and Growth Rate (2017-2022)

    • Table Sun Pharmaceutical Company Details

    • Table Sun Pharmaceutical Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Controlled Substances Main Business and Markets Served

    • Table Sun Pharmaceutical Controlled Substances Product Portfolio

    • Table Daiichi Sankyo Company Details

    • Table Daiichi Sankyo Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Controlled Substances Main Business and Markets Served

    • Table Daiichi Sankyo Controlled Substances Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Controlled Substances Main Business and Markets Served

    • Table Mylan Controlled Substances Product Portfolio

    • Table Teva Pharmaceuticals Company Details

    • Table Teva Pharmaceuticals Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Controlled Substances Main Business and Markets Served

    • Table Teva Pharmaceuticals Controlled Substances Product Portfolio

    • Table Purdue Pharma Company Details

    • Table Purdue Pharma Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma Controlled Substances Main Business and Markets Served

    • Table Purdue Pharma Controlled Substances Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Controlled Substances Main Business and Markets Served

    • Table GlaxoSmithKline Controlled Substances Product Portfolio

    • Table Medical Marijuana Inc Company Details

    • Table Medical Marijuana Inc Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medical Marijuana Inc Controlled Substances Main Business and Markets Served

    • Table Medical Marijuana Inc Controlled Substances Product Portfolio

    • Table Akorn Inc Company Details

    • Table Akorn Inc Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akorn Inc Controlled Substances Main Business and Markets Served

    • Table Akorn Inc Controlled Substances Product Portfolio

    • Table Tilray Company Details

    • Table Tilray Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tilray Controlled Substances Main Business and Markets Served

    • Table Tilray Controlled Substances Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Controlled Substances Main Business and Markets Served

    • Table Pfizer Controlled Substances Product Portfolio

    • Table Consort Medical Company Details

    • Table Consort Medical Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Consort Medical Controlled Substances Main Business and Markets Served

    • Table Consort Medical Controlled Substances Product Portfolio

    • Table Siegfried AG Company Details

    • Table Siegfried AG Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siegfried AG Controlled Substances Main Business and Markets Served

    • Table Siegfried AG Controlled Substances Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Controlled Substances Main Business and Markets Served

    • Table Johnson & Johnson Controlled Substances Product Portfolio

    • Table Takeda Pharmaceutical Company Details

    • Table Takeda Pharmaceutical Controlled Substances Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Controlled Substances Main Business and Markets Served

    • Table Takeda Pharmaceutical Controlled Substances Product Portfolio

    • Figure Global Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Depressants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Marijuana Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Controlled Substances Consumption Forecast by Country (2022-2028)

    • Table North America Controlled Substances Consumption Forecast by Country (2022-2028)

    • Figure United States Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Controlled Substances Consumption Forecast by Country (2022-2028)

    • Figure Germany Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Controlled Substances Consumption Forecast by Country (2022-2028)

    • Figure China Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Controlled Substances Consumption Forecast by Country (2022-2028)

    • Figure Brazil Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Controlled Substances Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Controlled Substances Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Controlled Substances Consumption Forecast by Country (2022-2028)

    • Figure Australia Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Controlled Substances Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US